Cargando…
Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins
A common strategy for exploring the biological roles of deubiquitinating enzymes (DUBs) in different pathways is to study the effects of replacing the wild‐type DUB with a catalytically inactive mutant in cells. We report here that a commonly studied DUB mutation, in which the catalytic cysteine is...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172466/ https://www.ncbi.nlm.nih.gov/pubmed/30150323 http://dx.doi.org/10.15252/embr.201745680 |
_version_ | 1783360952820826112 |
---|---|
author | Morrow, Marie E Morgan, Michael T Clerici, Marcello Growkova, Katerina Yan, Ming Komander, David Sixma, Titia K Simicek, Michal Wolberger, Cynthia |
author_facet | Morrow, Marie E Morgan, Michael T Clerici, Marcello Growkova, Katerina Yan, Ming Komander, David Sixma, Titia K Simicek, Michal Wolberger, Cynthia |
author_sort | Morrow, Marie E |
collection | PubMed |
description | A common strategy for exploring the biological roles of deubiquitinating enzymes (DUBs) in different pathways is to study the effects of replacing the wild‐type DUB with a catalytically inactive mutant in cells. We report here that a commonly studied DUB mutation, in which the catalytic cysteine is replaced with alanine, can dramatically increase the affinity of some DUBs for ubiquitin. Overexpression of these tight‐binding mutants thus has the potential to sequester cellular pools of monoubiquitin and ubiquitin chains. As a result, cells expressing these mutants may display unpredictable dominant negative physiological effects that are not related to loss of DUB activity. The structure of the SAGA DUB module bound to free ubiquitin reveals the structural basis for the 30‐fold higher affinity of Ubp8(C146A) for ubiquitin. We show that an alternative option, substituting the active site cysteine with arginine, can inactivate DUBs while also decreasing the affinity for ubiquitin. |
format | Online Article Text |
id | pubmed-6172466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61724662018-10-15 Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins Morrow, Marie E Morgan, Michael T Clerici, Marcello Growkova, Katerina Yan, Ming Komander, David Sixma, Titia K Simicek, Michal Wolberger, Cynthia EMBO Rep Articles A common strategy for exploring the biological roles of deubiquitinating enzymes (DUBs) in different pathways is to study the effects of replacing the wild‐type DUB with a catalytically inactive mutant in cells. We report here that a commonly studied DUB mutation, in which the catalytic cysteine is replaced with alanine, can dramatically increase the affinity of some DUBs for ubiquitin. Overexpression of these tight‐binding mutants thus has the potential to sequester cellular pools of monoubiquitin and ubiquitin chains. As a result, cells expressing these mutants may display unpredictable dominant negative physiological effects that are not related to loss of DUB activity. The structure of the SAGA DUB module bound to free ubiquitin reveals the structural basis for the 30‐fold higher affinity of Ubp8(C146A) for ubiquitin. We show that an alternative option, substituting the active site cysteine with arginine, can inactivate DUBs while also decreasing the affinity for ubiquitin. John Wiley and Sons Inc. 2018-08-27 2018-10 /pmc/articles/PMC6172466/ /pubmed/30150323 http://dx.doi.org/10.15252/embr.201745680 Text en © 2018 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Morrow, Marie E Morgan, Michael T Clerici, Marcello Growkova, Katerina Yan, Ming Komander, David Sixma, Titia K Simicek, Michal Wolberger, Cynthia Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins |
title | Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins |
title_full | Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins |
title_fullStr | Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins |
title_full_unstemmed | Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins |
title_short | Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins |
title_sort | active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172466/ https://www.ncbi.nlm.nih.gov/pubmed/30150323 http://dx.doi.org/10.15252/embr.201745680 |
work_keys_str_mv | AT morrowmariee activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT morganmichaelt activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT clericimarcello activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT growkovakaterina activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT yanming activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT komanderdavid activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT sixmatitiak activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT simicekmichal activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins AT wolbergercynthia activesitealaninemutationsconvertdeubiquitinasesintohighaffinityubiquitinbindingproteins |